Amyloid beta decreases acetylcholine and lung cancer cell survival through p38 MAPK, PKC, and p53 [Abstract]

Authors

• Stuti Goel*, Eastern Michigan University
• Aya Sabri*, Eastern Michigan University
• Brooke Lopo*, Eastern Michigan University
• Caroline Wozniak*, Eastern Michigan University
• Alvaro Cobos, Eastern Michigan University
• Jeffrey Guthrie, Eastern Michigan University
• Deborah Heyl-Clegg, Eastern Michigan University
• Hedeel Evans, Eastern Michigan University

Document Type

Article

Publication Date

2026

Department/School

Chemistry

Publication Title

Journal of Biological Chemistry

Comments

J. Guthrie, D. Heyl-Cleff, and H. Evans are faculty members in EMU's Department of Chemistry.

*S. Goel, A. Sabri, C. Wozniak, and Z. Cobos are EMU students.

Link to Published Version

DOI: 10.1016/j.jbc.2026.111567

Recommended Citation

Goel, S., Sabri, A., Lopo, B., Wozniak, C., Cobos, A., Guthrie, J., Heyl-Clegg, D., & Evans, H. (2026). Amyloid beta decreases acetylcholine and lung cancer cell survival through p38 MAPK, PKC, and p53 [Abstract]. Journal of Biological Chemistry, 302(5 Suppl), 111567. https://doi.org/10.1016/j.jbc.2026.111567